Hormone and Diabetes Treatments Ravenglass

Adiponectin is a metabolic hormone that regulates a number of processes, including glucose regulation and metabolism of fat for energy production. Previous research has shown an association between adiponectin and insulin sensitivity.

T Sowton
01229 718711
Chapel Lane
Millom

Data Provided by:
Bootle Surgery
01229 718711
Chapel Lane
Millom

Data Provided by:
R Jakobson
01946 820203
Beech House Group Practice
Egremont

Data Provided by:
J Den Bak
01946 820203
Beech House Group Practice
Egremont

Data Provided by:
F Galloway
01946 820203
Beech House Group Practice
Egremont

Data Provided by:
M Stevenson
01229 718711
Chapel Lane
Millom

Data Provided by:
P Carhart
01229 718711
Chapel Lane
Millom

Data Provided by:
Gallacher R Creed A & Margerison N Drs Surgery
01946 820348
66 Main Street
Egremont

Data Provided by:
J Veitch
01946 820203
Beech House Group Practice
Egremont

Data Provided by:
Egremont Physiofirst Ltd
01946 825402
16 Main Street
Egremont

Data Provided by:
Data Provided by:

Hormone and Diabetes Treatments

Provided By:

Adiponectin is a metabolic hormone that regulates a number of processes, including glucose regulation and metabolism of fat for energy production. Previous research has shown an association between adiponectin and insulin sensitivity.

This new study found that levels of the hormone in patients with type 2 diabetes helped predict how patients responded to certain diabetes drugs. The researchers' analysis of data from several clinical trials revealed that levels of adiponectin in the blood are able to predict activation of receptors called PPARs, which assist the genes that help cells respond to insulin.

The results support the possible use of adiponectin as a biomarker to monitor glucose tolerance and to predict patient response to diabetes drugs called thiazolidinediones.

The study appears in the June 24 online edition of Clinical Pharmacology & Therapeutics.

More information

The U.S. National Institute of Diabetes and Digestive Diseases has more about diabetes.

SOURCE: Clinical Pharmacology & Therapeutics, news release, June 24, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com